Study number: J2T-MC-KGAK/DRM06-AD18
NOW ENROLLING: the ADopt-VA study
With atopic dermatitis, itching isn’t even the worst part.
From the embarrassing red blotches to the painful sores, atopic dermatitis symptoms require the right treatment. You may qualify to participate in the ADopt-VA study for an injectable investigational medication.
To be eligible for the ADopt-VA study, you must:
• Be between the ages of 18 and 55 years old
• Have had moderate-to-severe AD for at least one year, with a history of inadequate response to topical treatments
• Have not recently received the Tdap (tetanus, diphtheria, and pertussis) or MCV (meningococcal) vaccines
This is not a complete list of study requirements. The study doctor will review all requirements with you.
To learn more about the ADopt-VA study, contact:
Ask your doctor if you are eligible for this clinical research study.
Contact us today!
15725 Pomerado Rd Suite 108, Poway, CA 92064
This study is funded by Eli Lilly & Company